SCHEMBL4540559

SCHEMBL4540559

O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccnn1-c1ncc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
PPARG P37231 1/20 0.51
NR2E3 Q9Y5X4 1/20 0.51
NCOR2 Q9Y618 1/20 0.51
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
RECQL P46063 2/20 0.42
GLA P06280 1/20 0.41
SLC40A1 Q9NP59 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 2/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4540339 0.83 MEN1 (0.70) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4543579 0.82 SMN1; SMN2 (0.55) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4540440 0.81 MAPK14 (0.48) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4540280 0.81 DGAT2 (0.44) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4542986 0.80 MEN1 (0.49) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4541107 0.80 MEN1 (0.49) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4543630 0.79 MEN1 (0.53) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4538837 0.78 MAPK1 (0.46) NPSR1KDM4ECYP1A2CYP3A4GAA
SCHEMBL4543701 0.78 MEN1 (0.75) MEN1KMT2APPARGNR2E3NCOR2
SCHEMBL4538115 0.78 NPC1 (0.48) MEN1KMT2APPARGNR2E3NCOR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed